Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposomal PureWay-C is a proprietary nutraceutical ingredient developed by ONE Innovation Labs, featuring a liposomal delivery system for PureWay-C, a specialized form of vitamin C. PureWay-C itself is composed of ascorbic acid combined with lipid metabolites and citrus bioflavonoids, which are intended to enhance the absorption, cellular uptake, and retention of the vitamin. The liposomal encapsulation further protects the nutrient through the digestive tract and facilitates its transport across cell membranes. It is primarily marketed for use in dietary supplements to provide antioxidant support, enhance immune function, and promote collagen synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liposomal PureWay-C.